While Bs potential is broad, do think IPIX will keep it focused on IBD in near term w prob some work on Derm, given Dr Bertolini as a dermatologist.
ABSSSI prob also not out of picture, pending partnering/financing.
Kevetrin - however, once oral, and if it does what we hope it might do... well, then, that might be Ibuprofen-like. Instead of keeping the headache away, it'll be for helping keep the cancer at bay.
News 
Market Data 
Discover 
